Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
BMC Health Serv Res ; 20(1): 913, 2020 Oct 02.
Article in English | MEDLINE | ID: covidwho-810411

ABSTRACT

BACKGROUND: Novel Coronavirus is a global pandemic affecting all walks of life and it significantly changed the health system practices. Pharmacists are at the front line and have long been involved in combating this public health emergency. Therefore, the study was aimed to explore pharmacy preparedness and response to prevent and control coronavirus disease 2019 (COVID-19). METHODS: A qualitative study was conducted in six pharmacies in Aksum, Ethiopia in May, 2020. We conducted six in-depth interviews with purposively selected key informants. Direct observation measures were made to assess the activities made in the medicine retail outlets for the prevention and control of the pandemic. Interview data were audio-recorded, translated and transcribed verbatim. Thematic analysis was employed to analyze the data and OpenCode version 4.02 software was used to facilitate the data analysis. RESULTS: The thematic analysis has resulted in seven major themes. Good preparedness measures were undertaken to control and prevent COVID-19. Study informants had good knowledge about the pandemic disease and reported they had used different resource materials to update themselves. Preparing of alcohol-based hand-rub, availing finished sanitizers and alcohol, and advising clients to maintain physical distancing were the major counseling information being delivered to prevent the disease. Some tendencies of irrational drug use and false claims of COVID-19 were observed at the beginning of the pandemic. Interview informants had reported they were working with relevant stakeholders and appropriate patient education and support were given to combat the pandemic. CONCLUSION: The study revealed necessary pharmacy services has been rendered to all clients. However, availability of drugs and medical supplies were scarce which negatively affected the optimal delivery of pharmacy services. The government and other responsible bodies should work together to solve such problems and contain the pandemic.


Subject(s)
Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pharmaceutical Services/organization & administration , Pharmacists/psychology , Pneumonia, Viral/prevention & control , Adult , COVID-19 , Coronavirus Infections/drug therapy , Coronavirus Infections/epidemiology , Ethiopia/epidemiology , Female , Health Services Research , Humans , Male , Middle Aged , Pharmaceutical Preparations/supply & distribution , Pharmacists/statistics & numerical data , Qualitative Research , COVID-19 Drug Treatment
2.
Emerg Microbes Infect ; 9(1): 1372-1378, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-598768

ABSTRACT

Background: According to the World Health Organization (WHO), the outbreak of coronavirus disease in 2019 (COVID-19) has been declared as pandemic and public health emergency that infected more than 5 million people worldwide at the time of writing this protocol. Strong evidence for the burden, admission, and outcome of COVID-19 has not been published in Africa. Therefore, this protocol will be served as a guideline to conduct a systematic review and meta-analysis of the burden, admission, and outcome of COVID-19 in Africa. Methods: Published and unpublished studies on the burden, admission, and outcome of COVID-19 in Africa and written in any language will be included. Databases (PubMed / MEDLINE, Google Scholar, Google, EMBASE, Web of Science, Microsoft Academic, WHO COVID-19 database, Cochran Library, Africa Wide Knowledge, and Africa Index Medicus) from December 2019 to May 2020 will be searched. Two independent reviewers will select, screen, extract data, and assess the risk of bias. The proportion will be measured using a random-effects model. Subgroup analysis will be conducted to manage hetrogeinity. The presence of publication bias will be assessed using Egger's test and visual inspection of the funnel plots. This systematic and meta-analysis review protocol will be reported per the PRISMA-P guidelines. Conclusion: This systematic review and meta-analysis protocol will be expected to quantify the burden, admission, and outcome of COVID-19 in Africa. Systematic review registration: This protocol was submitted for registration with the International Prospective Register of Systematic Reviews (PROSPERO) in March 2020 and accepted with the registration number: CRD42020179321(https://www.crd.york.ac.uk/PROSPERO).


Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/epidemiology , Meta-Analysis as Topic , Pandemics , Pneumonia, Viral/epidemiology , Practice Guidelines as Topic , Systematic Reviews as Topic , Africa/epidemiology , Betacoronavirus/isolation & purification , COVID-19 , COVID-19 Testing , Civil Defense/economics , Clinical Laboratory Techniques/methods , Coronavirus Infections/diagnosis , Coronavirus Infections/economics , Coronavirus Infections/transmission , Developing Countries/economics , Humans , Incidence , Pandemics/economics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/economics , Pneumonia, Viral/transmission , SARS-CoV-2 , World Health Organization
SELECTION OF CITATIONS
SEARCH DETAIL